Miscellaneous amused views on topics in the domains of neuropsychiatric epidemiology, defined broadly to encompass the entire envirome and genome, including infective agents; alcohol, tobacco, and other drugs; traumatic events; you name it. Comments welcome. Will be moderated by a volunteer among one of our MSU program's chief fellows or alum.
Monday, April 9, 2018
Friday, April 6, 2018
Hard and soft drugs: reasons to avoid using these terms
Link to a critique, Janek et al., 2017
To cite this article: Peter Janik, Michaela Kosticova, Jan Pecenak Prof & Michal Turcek (2017) Categorization of psychoactive substances into “hard drugs” and “soft drugs”: a critical review of terminology used in current scientific literature, The American Journal of Drug and Alcohol Abuse, 43:6, 636-646, DOI: 10.1080/00952990.2017.1335736
Thursday, April 5, 2018
The X-Plan: ripe for a group-randomized trial.
DP5 material
Wednesday, April 4, 2018
New forms of nicotine products in the news.
Some epidemiological evidence in that article.
Anyone done a case-crossover study yet?
Tuesday, April 3, 2018
Monday, April 2, 2018
Opioids, cannabis, and pain: Use STROBE to analyze.
What is missing?
Subscribe to:
Posts (Atom)